Clinician perspectives on barriers and facilitators to the treatment of adolescent cannabis use: A qualitative study

被引:0
|
作者
Mian, Maha N. [1 ,2 ,3 ]
Annam, Jay [4 ]
Altschuler, Andrea [2 ]
Does, Monique B. [2 ]
Sterling, Stacy A. [2 ,3 ]
Satre, Derek D. [2 ,3 ]
Campbell, Cynthia I. [2 ,3 ]
Asyyed, Asma H. [5 ]
Silver, Lynn D. [6 ]
Cunningham, Sarah F. [2 ]
Young-Wolff, Kelly C. [2 ,3 ]
机构
[1] Suffolk Univ, Dept Psychol, Boston, MA 02108 USA
[2] Kaiser Permanente Northern Calif, Div Res, Pleasanton, CA USA
[3] Univ Calif San Francisco, Weill Inst Neurosci, Dept Psychiat & Behav Sci, San Francisco, CA USA
[4] Kaiser Permanente Oakland Med Ctr, Dept Psychiat, Oakland, CA USA
[5] Kaiser Permanente Northern Calif, Reg Off, Oakland, CA USA
[6] Publ Hlth Inst, Oakland, CA USA
来源
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT | 2025年 / 169卷
关键词
cannabis; Marijuana; Adolescents; Substance use treatment; BEHAVIORAL TREATMENTS; MENTAL-HEALTH; SUBSTANCE USE; ATTITUDES;
D O I
10.1016/j.josat.2024.209559
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Cannabis use among adolescents is prevalent, and clinicians who work with adolescents have unique insights about how to treat cannabis use in this population. Methods: This qualitative study interviewed 32 clinicians from addiction medicine recovery services (AMRS), the emergency department (ED), mental health (MH), and pediatrics in an integrated healthcare system to understand their perspectives and experiences regarding barriers and facilitators to treating adolescent cannabis use. The analysis was developed using thematic analysis of interviews. Results: Thirty-two clinicians (Mean age = 45.9, SD =7.6; 56.3 % Female; 56.3 % White) were recruited from AMRS (n = 13; 41.6 %), the ED (n = 7; 21.9 %), MH (n = 7; 21.9 %) and pediatrics (n = 5; 15.6 %). Clinicians discussed several key barriers and facilitators of treating adolescent cannabis use. Facilitators include the use of multiple screening tools for adolescent cannabis use (i.e., self-report and toxicology testing) which provide more comprehensive information; patient-centered treatment approaches; and discussing cannabis use in the context of adolescents' mental health. Barriers discussed included adolescents' and parents' minimization of adolescent cannabis use risks. Several factors were discussed as potential facilitators or barriers, depending on context, including the influence of peers, virtual treatment, and parental involvement or lack thereof in treatment. Conclusions: Interviews with clinicians who work with adolescents across settings highlighted factors that serve as barriers and facilitators to treating adolescent cannabis use. These findings have important implications for guiding future research and intervention efforts, including the inclusion of universal screening practices, addressing stigma, reducing adolescents' and parents' minimization of cannabis use-related harms, and improving adolescent and parent engagement in treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Facilitators and barriers of herbal medicine use in diabetic patients: A qualitative study
    Vaezi, Ali Akbar
    Sotoudeh, Ahmad
    Namiranian, Nasim
    Ardakani, Mojtaba Fattahi
    Zareipour, Moradali
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2021, 10 (01)
  • [42] The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study
    Udas, Summita
    Chand, Obindra Bahadur
    Shrestha, Babin
    Pathak, Sushmita
    Syantang, Sarita
    Dahal, Ashata
    Karkey, Abhilasha
    Giri, Abhishek
    Shilpakar, Olita
    Basnyat, Buddha
    Salami, Olawale
    Nkeramahame, Juvenal
    Olliaro, Piero
    Horgan, Philip
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [43] Qualitative Assessment of Barriers and Facilitators to HIV Treatment
    Williams, Bryman
    Amico, K. Rivet
    Konkle-Parker, Deborah
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2011, 22 (04): : 307 - 312
  • [44] Barriers and facilitators for adolescent girls to take on adult responsibility for dental care ? a qualitative study
    Fagerstad, Anida
    Lundgren, Jesper
    Arnrup, Kristina
    Carlson, Eva
    INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING, 2019, 14 (01)
  • [45] Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study
    Sanjobo, Nawa
    Frich, Jan C.
    Fretheim, Atle
    SAHARA J-JOURNAL OF SOCIAL ASPECTS OF HIV-AIDS, 2008, 5 (03) : 136 - 143
  • [46] Barriers and Facilitators to Mobile Application Use During PTSD Treatment: Clinician Adoption of PE Coach
    Reger, Greg M.
    Browne, Kendall C.
    Campellone, Timothy R.
    Simons, Carol
    Kuhn, Eric
    Fortney, John C.
    Sayre, George G.
    Reisinger, Heather Schacht
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2017, 48 (06) : 510 - 517
  • [47] Managing treatment for end-stage renal disease - A qualitative study exploring cultural perspectives on facilitators and barriers to treatment adherence
    Griva, K.
    Ng, H. J.
    Loei, J.
    Mooppil, N.
    McBain, H.
    Newman, S. P.
    PSYCHOLOGY & HEALTH, 2013, 28 (01) : 13 - 29
  • [48] Facilitators and Barriers in Treatment Seeking for Substance Use Disorders: Indian Clinical Perspectives
    Perumbilly, Sebastian A.
    Melendez-Rhodes, Tatiana
    Anderson, Stephen A.
    ALCOHOLISM TREATMENT QUARTERLY, 2019, 37 (02) : 240 - 256
  • [49] Barriers and Facilitators of Palliative Care Referrals for Patients with Cirrhosis: A Qualitative Study of Clinical Perspectives
    Thakur, Kshitij
    Grigorian, Alla
    McFarlin, Jessica
    Merritt, Allison
    Stapleton, Jerod
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1129 - S1129
  • [50] PERCEIVED BARRIERS AND FACILITATORS FOR BDMARD DOSE OPTIMIZATION: A QUALITATIVE STUDY INTO RA PATIENTS' PERSPECTIVES
    Verhoef, L. M.
    Selten, E. M.
    van den Hoogen, F.
    den Broeder, A. A.
    Hulscher, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1272 - 1272